Connection

Hermes Florez to Hypoglycemic Agents

Back to Details
This is a "connection" page, showing publications Hermes Florez has written about Hypoglycemic Agents.
Hermes Florez
Connection Strength
4.242
Hypoglycemic Agents
  1. Metformin and ageing: improving ageing outcomes beyond glycaemic control. Diabetologia. 2017 09; 60(9):1630-1638.
    View in: PubMed
    Score: 0.465
  2. Pharmacological treatment of diabetes in older people. Diabetes Obes Metab. 2014 Dec; 16(12):1192-203.
    View in: PubMed
    Score: 0.380
  3. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance. Diabetes Obes Metab. 2014 Apr; 16(4):326-33.
    View in: PubMed
    Score: 0.358
  4. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes. Postgrad Med. 2010 Mar; 122(2):112-20.
    View in: PubMed
    Score: 0.278
  5. Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring. Diabetes Technol Ther. 2019 12; 21(12):682-690.
    View in: PubMed
    Score: 0.269
  6. Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up. N Engl J Med. 2019 Jun 06; 380(23):2215-2224.
    View in: PubMed
    Score: 0.264
  7. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015 Jun 04; 372(23):2197-206.
    View in: PubMed
    Score: 0.200
  8. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015 Apr; 100(4):1646-53.
    View in: PubMed
    Score: 0.196
  9. Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study. J Gerontol A Biol Sci Med Sci. 2021 04 30; 76(5):929-936.
    View in: PubMed
    Score: 0.151
  10. Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. Diabetes Care. 2020 05; 43(5):940-947.
    View in: PubMed
    Score: 0.139
  11. Suitable Use of Injectable Agents to Overcome Hypoglycemia Risk, Barriers, and Clinical Inertia in Community-Dwelling Older Adults with Type 2 Diabetes Mellitus. Drugs Aging. 2019 12; 36(12):1083-1096.
    View in: PubMed
    Score: 0.137
  12. Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2019 11; 42(11):2098-2107.
    View in: PubMed
    Score: 0.134
  13. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet. 2019 07 13; 394(10193):131-138.
    View in: PubMed
    Score: 0.132
  14. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 07 13; 394(10193):121-130.
    View in: PubMed
    Score: 0.132
  15. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study. Ann Intern Med. 2019 05 21; 170(10):682-690.
    View in: PubMed
    Score: 0.131
  16. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009 Jan 08; 360(2):129-39.
    View in: PubMed
    Score: 0.128
  17. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care. 2018 08; 41(8):1672-1680.
    View in: PubMed
    Score: 0.123
  18. A new angle for glp-1 receptor agonist: the medical economics argument. Editorial on: Huetson P, Palmer JL, Levorsen A, et al. Cost-effectiveness of the once-daily glp-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway. J Med Econ 2015: 1-13 [Epub ahead of print]. J Med Econ. 2015; 18(12):1029-31.
    View in: PubMed
    Score: 0.102
  19. Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial. Diabetes Obes Metab. 2015 Oct; 17(10):949-55.
    View in: PubMed
    Score: 0.100
  20. The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures. Diabetes Care. 2021 01; 44(1):43-49.
    View in: PubMed
    Score: 0.073
  21. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet. 2020 07; 52(7):680-691.
    View in: PubMed
    Score: 0.071
  22. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14; 374(9702):1677-86.
    View in: PubMed
    Score: 0.068
  23. The Avandia debacle: methodology and practical importance of the findings. South Med J. 2007 Nov; 100(11):1062-3.
    View in: PubMed
    Score: 0.059
  24. Long-term effects of lifestyle and metformin interventions in DPP on bone density. Osteoporos Int. 2021 Nov; 32(11):2279-2287.
    View in: PubMed
    Score: 0.038
  25. Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2017 07; 40(7):958-965.
    View in: PubMed
    Score: 0.029
  26. Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association. Diabetes Care. 2016 Feb; 39(2):308-18.
    View in: PubMed
    Score: 0.026
  27. Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study. Qual Life Res. 2014 Feb; 23(1):75-88.
    View in: PubMed
    Score: 0.022
  28. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012 Dec; 60(12):2342-56.
    View in: PubMed
    Score: 0.021
  29. Strict glycemic control and mortality risk among US adults with type 2 diabetes. J Diabetes Complications. 2011 Sep-Oct; 25(5):289-91.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.